4//SEC Filing
Novus Therapeutics, Inc. 4
Accession 0000899243-17-018152
$ELDNCIK 0001404281operating
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 5:31 PM ET
Size
5.7 KB
Accession
0000899243-17-018152
Insider Transaction Report
Form 4
Kuwahara Jon
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-07-10+35,000→ 35,000 totalExercise: $5.61Exp: 2027-07-10→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 35,000 shares of the Issuer's Common Stock one quarter of which will become fully vested and exercisable on 7/10/2018, with the remaining 26,250 shares vesting in equal quarterly installments over the following three years.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001404281
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 5:31 PM ET
- Size
- 5.7 KB